Results 1 - 10 of 475
[REPORT SUMMARY] Final Report Summary - EUROCANPLATFORM (A European Platform for Translational Cancer Research)
The EurocanPlatform brought together 28 European cancer Institutions and organisations to work in partnership to structure translational research. The centres shared infrastructures, expertise and collaborated on projects to innovate in cancer research. The overarching aim of...
Programme: FP7-HEALTH
Record Number: 201649
Last updated on: 2017-07-25
[REPORT SUMMARY] Periodic Report Summary 4 - RATHER (Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes)
Project Context and Objectives: Cancer genotyping has identified a number of correlations between mutations in specific genes and responses to targeted anti-cancer drugs, with many mutations occurring in kinases or downstream signalling components. The RATHER consortium are...
Programme: FP7-HEALTH
Record Number: 201776
Last updated on: 2017-07-25
Severe birth asphyxia (BA) is a life-threatening condition of the newborn, with an annual death rate of a million neonates globally. It is typically caused by compromised umbilical/placental functions during complicated delivery which leads to a fall in the oxygen level and...
Programme: FP7-IDEAS-ERC
Record Number: 201451
Last updated on: 2017-07-24
As a result of the rapidly growing human population, mankind faces the enormous challenge to increase agricultural productivity while decreasing our ecological footprint in a changing climate. Plants are continuously threatened by a multitude of pathogens and pests, resulting...
Programme: FP7-IDEAS-ERC
Record Number: 201450
Last updated on: 2017-07-24
[REPORT SUMMARY] Final Report Summary - PANCARESURFUP (PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies)
WP1 in PCSF has gathered the largest cohort of childhood cancer patients ever collected with 115,596 individuals, of whom 83,333 are 5-year survivors, from 13 data providers in 12 European countries. Each 5-year survivor in the cohort studies contributed data on basic...
Programme: FP7-HEALTH
Record Number: 199817
Last updated on: 2017-06-21
[REPORT SUMMARY] Final Report Summary - E3 (E3 - Extreme Event Ecology)
With global warming, extreme events are very likely to change in intensity and/or frequency and location. The successfully answered leading question of E3 (Extreme Event Ecology) was how (physical) extreme events translate into (biological) extreme impacts. The assessed...
Programme: FP7-IDEAS-ERC
Record Number: 199917
Last updated on: 2017-06-20
[REPORT SUMMARY] Final Report Summary - AVECNET (African Vector Control: New Tools)
Prevention of malaria is best achieved by vector control which, today in Africa, relies almost entirely on the use of residual insecticides in the domestic environment. Wide scale implementation of tools such as indoor residual spraying (IRS) and long lasting insecticidal nets...
Programme: FP7-HEALTH
Record Number: 199585
Last updated on: 2017-06-20
[REPORT SUMMARY] Final Report Summary - SET-NET (Enzymatic and genomic targets of histone modifying enzymes and their role in liver metabolism and hepatocarcinogenesis.)
In this program we studied the role of histone methylases and demethylases in liver development, in the pathogenesis of hepatocarcinogenesis and in the regulation of hepatic metabolic pathways. Focus was on Set9, Smyd2 Smyd3, PR-Set7 and LSD1 enzymes. We have generated several...
Programme: FP7-IDEAS-ERC
Record Number: 198005
Last updated on: 2017-05-12
[REPORT SUMMARY] Final Report Summary - EXPLOGEN (Exploitation of actinomycetes genomics using synthetic and system biology approaches)
The major aim of the project is the exploitation of the biosynthetic potential of actinobacteria in order to produce bioactive compounds. Using synthetic and system biology approaches we aim to access these so far unavailable natural products. The major components of our...
Programme: FP7-IDEAS-ERC
Record Number: 197998
Last updated on: 2017-05-12
[REPORT SUMMARY] Final Report Summary - IMPACTT (Immunoglobulin IgY pseudomonas A clinical trial for cystic fibrosis treatment)
IMPACTT was supported by the European Union Seventh Framework Programme. IMPACTT started on January 1st 2011 as a collaboration between ten partners from seven European countries: Sweden, Germany, Denmark, Belgium, France, Italy and Lithuania. The project has since expanded to...
Programme: FP7-HEALTH
Record Number: 197704
Last updated on: 2017-05-10
List retrieved on: 2017-08-02
